Consensus for HER2 alterations testing in non-small-cell lung cancerShengxiang Ren, Fred R. Hirsch, Daniel Lee et al.|ESMO Open|2022Cited by 110
Real‐world data on EGFR/ALK gene status and first‐line targeted therapy rate in newly diagnosed advanced non‐small cell lung cancer patients in Northern China: A prospective observational studyHongge Liang, Mengzhao Wang, Xia Song et al.|Thoracic Cancer|2019Cited by 26